2016: The year of digital health and recalibration

As 2016 comes to a close, the year has had its share of ups and downs. But looking specifically at the healthcare field, the year proved to be one of recalibration.

With new technologies like wearables and mobile apps taking over the market, digital health has continued to improve personalized precision care. Healthcare is faster and more efficient, but the gap between the promises of technology and the progress itself has become more apparent.

“Fortunately, 2016 was characterized by a much-needed recalibration, as the gap between technology’s promise and medicine’s progress became more readily apparent,” wrote author David Shaywitz. “Precision medicine is still largely aspirational, and the demonstrated utility of digital health remains, for the most part, a hope waiting to be fulfilled.”

Read Shaywitz’s full article by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.